Leadhopping – and beyond
暂无分享,去创建一个
[1] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[2] R. Cramer,et al. Prospective identification of biologically active structures by topomer shape similarity searching. , 1999, Journal of medicinal chemistry.
[3] Ajay N. Jain,et al. Robust ligand-based modeling of the biological targets of known drugs. , 2006, Journal of medicinal chemistry.
[4] Ajay N. Jain,et al. Parameter estimation for scoring protein-ligand interactions using negative training data. , 2006, Journal of medicinal chemistry.
[5] S. Muchmore,et al. The Use of Three‐Dimensional Shape and Electrostatic Similarity Searching in the Identification of a Melanin‐Concentrating Hormone Receptor 1 Antagonist , 2006, Chemical biology & drug design.
[6] Robert D. Clark,et al. Virtual Compound Libraries: A New Approach to Decision Making in Molecular Discovery Research , 1998, J. Chem. Inf. Comput. Sci..
[7] Ajay N. Jain,et al. Ligand-based structural hypotheses for virtual screening. , 2004, Journal of medicinal chemistry.
[8] Schmid,et al. "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.
[9] J. G. Vinter,et al. Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists. , 2005, Journal of medicinal chemistry.
[10] Yvonne C. Martin,et al. Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection , 1996, J. Chem. Inf. Comput. Sci..
[11] K Jarnagin,et al. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. , 2001, Cancer research.
[12] Robert J. Jilek,et al. Topomers: A Validated Protocol for Their Self-Consistent Generation , 2004, J. Chem. Inf. Model..
[13] G. Schneider,et al. New Allosteric Modulators of Metabotropic Glutamate Receptor 5 (mGluR5) Found by Ligand‐Based Virtual Screening , 2005, Chembiochem : a European journal of chemical biology.
[14] Naomie Salim,et al. Analysis and Display of the Size Dependence of Chemical Similarity Coefficients , 2003, J. Chem. Inf. Comput. Sci..
[15] J. Jenkins,et al. A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. , 2004, Journal of medicinal chemistry.
[16] Peter Willett,et al. Scaffold Hopping Using Clique Detection Applied to Reduced Graphs , 2006, J. Chem. Inf. Model..
[17] Robert J. Jilek,et al. AllChem: generating and searching 1020 synthetically accessible structures , 2007, J. Comput. Aided Mol. Des..
[18] R. Cramer,et al. SUBSTRUCTURAL ANALYSIS, A NOVEL APPROACH TO THE PROBLEM OF DRUG DESIGN , 1974 .
[19] J. A. Grant,et al. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.
[20] Lars Naerum,et al. Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors. , 2002, Bioorganic & medicinal chemistry letters.
[21] Ian A. Watson,et al. ErG: 2D Pharmacophore Descriptions for Scaffold Hopping. , 2006 .
[22] Robert J. Jilek,et al. "Lead hopping". Validation of topomer similarity as a superior predictor of similar biological activities. , 2004, Journal of medicinal chemistry.
[23] Qiang Zhang,et al. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. , 2006, Journal of medicinal chemistry.
[24] R. Cramer,et al. Toward general methods of targeted library design: topomer shape similarity searching with diverse structures as queries. , 2000, Journal of medicinal chemistry.
[25] R. Cramer,et al. Topomer CoMFA: a design methodology for rapid lead optimization. , 2003, Journal of medicinal chemistry.
[26] Maria A Miteva,et al. Fast structure-based virtual ligand screening combining FRED, DOCK, and Surflex. , 2005, Journal of medicinal chemistry.
[27] Andy Vinter,et al. Molecular Field Extrema as Descriptors of Biological Activity: Definition and Validation , 2006, J. Chem. Inf. Model..
[28] Robert D Clark,et al. Bioisosterism as a molecular diversity descriptor: steric fields of single "topomeric" conformers. , 1996, Journal of medicinal chemistry.
[29] Robert D Clark,et al. Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. , 1996, Journal of medicinal chemistry.
[30] S. Wold,et al. Comparative molecular field analysis , 1991 .
[31] B. Masek,et al. Molecular shape comparison of angiotensin II receptor antagonists. , 1993, Journal of medicinal chemistry.
[32] R. Cramer,et al. Dbtop: topomer similarity searching of conventional structure databases. , 2002, Journal of molecular graphics & modelling.
[33] Andrew C. Good,et al. Descriptors you can count on? Normalized and filtered pharmacophore descriptors for virtual screening , 2004, J. Comput. Aided Mol. Des..
[34] E. Jaeger,et al. Comparison of automated docking programs as virtual screening tools. , 2005, Journal of Medicinal Chemistry.
[35] P. Willett,et al. A Comparison of Some Measures for the Determination of Inter‐Molecular Structural Similarity Measures of Inter‐Molecular Structural Similarity , 1986 .
[36] G. S. Gill,et al. Molecular surface point environments for virtual screening and the elucidation of binding patterns (MOLPRINT) , 2004 .
[37] J. A. Grant,et al. A Gaussian Description of Molecular Shape , 1995 .
[38] Thomas Lengauer,et al. Novel technologies for virtual screening. , 2004, Drug discovery today.
[39] Jin Li,et al. On Evaluating Molecular-Docking Methods for Pose Prediction and Enrichment Factors , 2006, J. Chem. Inf. Model..
[40] Ajay N. Jain. Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. , 2003, Journal of medicinal chemistry.
[41] Lirong Chen,et al. 3D QSAR Analyses of Novel Tyrosine Kinase Inhibitors Based on Pharmacophore Alignment. , 2001 .
[42] Andreas Evers,et al. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols. , 2005, Journal of medicinal chemistry.
[43] Robert D. Clark,et al. Structural Unit Analysis Identifies Lead Series and Facilitates Scaffold Hopping in Combinatorial Chemistry. , 2006 .